Daphne S. Bakker - Concepedia

Author

Daphne S. Bakker

Also Known As

Bakker, Daphne Suzanna, D. Bakker, D.S. Bakker, Daphne Bakker, Daphne S Bakker, Daphne S. Bakker, Daphne S Bakker, Dr Emyr Bakker

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University Medical Center Utrecht Utrecht University Radboud University Medical Center Radboud University Nijmegen University Medical Center Groningen

About

Daphne S. Bakker is an author at University Medical Center Utrecht specializing in dermatology, medicine, and ophthalmology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	224
2	Allergy Medicine	2	2	113
3	Allergy	1	1	25
4	Immunology	1	1	56
5	Autoimmunity	1	1	56

Daphne S. Bakker

Publications

953

Citations

H-Index

Page 1

	Year	Citations
Dupilumab is very effective in a large cohort of difficult‐to‐treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry Lieneke F.M. Ariëns, Jorien van der Schaft, Daphne S. Bakker, Allergy	2019	146
Confirmation of multiple endotypes in atopic dermatitis based on serum biomarkers Daphne S. Bakker, Stefan Nierkens, Edward F. Knol, Journal of Allergy and Clinical Immunology	2020	119
Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry Lieneke F.M. Ariëns, Jorien van der Schaft, Lotte S. Spekhorst, Journal of the American Academy of Dermatology Atopic DermatitisAllergy MedicineOutcomes ResearchDutch Bioday RegistryDaily Practice	2020	88
Early and Long-Term Effects of Dupilumab Treatment on Circulating T-Cell Functions in Patients with Moderate-to-Severe Atopic Dermatitis Daphne S. Bakker, Marlot van der Wal, Lukas E. M. Heeb, Journal of Investigative Dermatology	2021	78
Dupilumab facial redness: Positive effect of itraconazole Fleur S.A. de Beer, Daphne S. Bakker, Inge Haeck, JAAD Case Reports InflammationDupilumab Facial RednessOphthalmologyAtopic DermatitisImmunodeficiencies	2019	56
Long-term follow-up and treatment outcomes of conjunctivitis during dupilumab treatment in patients with moderate-to-severe atopic dermatitis Roselie Achten, Daphne S. Bakker, Lieneke F.M. Ariëns, The Journal of Allergy and Clinical Immunology In Practice OphthalmologyDupilumab TreatmentAtopic DermatitisModerate-to-severe Atopic DermatitisContact Dermatitis	2020	55
Patient‐centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis Lotte S. Spekhorst, Daphne S. Bakker, Julia Drylewicz, Allergy	2022	54
Dupilumab-Associated Lymphoid Reactions in Patients With Atopic Dermatitis Celeste M. Boesjes, Lian F. van der Gang, Daphne S. Bakker, JAMA Dermatology	2023	50
Unraveling heterogeneity in pediatric atopic dermatitis: Identification of serum biomarker based patient clusters Daphne S. Bakker, Marlies de Graaf, Stefan Nierkens, Journal of Allergy and Clinical Immunology	2021	41
Successful tapering of dupilumab in patients with atopic dermatitis with low disease activity: a large pragmatic daily practice study from the BioDay registry Lotte S. Spekhorst, Celeste M. Boesjes, Laura Loman, British Journal of Dermatology	2023	38

Page 1